BOJHT
RXRX icon

Bank of Jackson Hole Trust’s Recursion Pharmaceuticals RXRX Stock Holding History

Bank of Jackson Hole Trust’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.1K Buy
1,008
+242
+32% +$935 ﹤0.01% 472
2025
Q4 		$3.13K Buy
+766
New +$3.79K ﹤0.01% 480

Other funds holding RXRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of Jackson Hole Trust's RXRX Position: Q1 2026 in Review

Bank of Jackson Hole Trust increased its Recursion Pharmaceuticals (RXRX) stake by 32% in Q1 2026, buying an estimated $935 and bringing the position to 1,008 shares worth $3.1K. The position accounts for ﹤0.01% of the portfolio, ranked #472.

Bank of Jackson Hole Trust first reported a position in RXRX in Q4 2025 and has held it in 2 quarters since. The position peaked at $3.13K in Q4 2025. 334 funds tracked by Wall St. Rank hold RXRX as of Q1 2026.

  • Bank of Jackson Hole Trust held 1,008 shares of Recursion Pharmaceuticals worth $3.1K as of Q1 2026.
  • Bank of Jackson Hole Trust bought 242 Recursion Pharmaceuticals shares in Q1 2026, an estimated $935.
  • Recursion Pharmaceuticals made up ﹤0.01% of Bank of Jackson Hole Trust's portfolio in Q1 2026, its #472 holding.
  • Bank of Jackson Hole Trust first reported a position in Recursion Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • Bank of Jackson Hole Trust's Recursion Pharmaceuticals position peaked at $3.13K in Q4 2025.
  • 334 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q1 2026.

Based on Bank of Jackson Hole Trust's 13F filing for Q1 2026, filed 12 May 2026.